trial · primary record
Rapamycin
Healthspan Improvement
| Phase | Phase 3 |
|---|---|
| Status | COMPLETED |
| Sponsor | Unknown |
| Enrolment | 26 |
| Primary completion | 2026-04-09 |
| Primary endpoint | Change in cardiorespiratory fitness measured by maximal oxygen uptake (VO₂ max) |
| Registry ID | NCT07475546 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-30T14:43:27.202Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07475546
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.